OFI Invest Asset Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.5M Sell
199,735
-24,253
-11% -$10.6M 0.69% 33
2026
Q1
$89.7M Buy
223,988
+64,979
+41% +$32.9M 1.19% 18
2025
Q4
$76.7M Buy
159,009
+34,933
+28% +$18.6M 1.1% 16
2025
Q3
$47.2M Buy
124,076
+16,494
+15% +$7.92M 0.99% 27
2025
Q2
$49.8M Buy
107,582
+99,069
+1,164% +$51.8M 1.24% 20
2025
Q1
$3.9M Buy
8,513
+363
+4% +$201K 0.1% 103
2024
Q4
$4.11M Buy
+8,150
New +$4.24M 0.1% 109
2024
Q2
$3.91M Buy
9,409
+7,894
+521% +$3.14M 0.1% 106
2024
Q1
$560K Sell
1,515
-649
-30% -$245K 0.02% 149
2023
Q4
$661K Buy
2,164
+2,073
+2,278% +$618K 0.02% 143
2023
Q3
$25.1K Buy
+91
New +$28.4K ﹤0.01% 201
2023
Q2
Sell
-207,186
Closed -$811K 129
2023
Q1
$811K Buy
+207,186
New +$51M ﹤0.01% 126

Other funds holding ISRG

OFI Invest Asset Management's ISRG Position: Q2 2026 in Review

OFI Invest Asset Management reduced its Intuitive Surgical (ISRG) stake by 11% in Q2 2026, selling an estimated $10.6M and leaving 199,735 shares worth $69.5M. The position accounts for 0.69% of the portfolio, ranked #33.

OFI Invest Asset Management first reported a position in ISRG in Q1 2023 and has held it in 12 quarters since. The position peaked at $89.7M in Q1 2026. 2,231 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • OFI Invest Asset Management held 199,735 shares of Intuitive Surgical worth $69.5M as of Q2 2026.
  • OFI Invest Asset Management sold 24,253 Intuitive Surgical shares in Q2 2026, an estimated $10.6M.
  • Intuitive Surgical made up 0.69% of OFI Invest Asset Management's portfolio in Q2 2026, its #33 holding.
  • OFI Invest Asset Management first reported a position in Intuitive Surgical in Q1 2023 and has held it in 12 quarters since.
  • OFI Invest Asset Management's Intuitive Surgical position peaked at $89.7M in Q1 2026.
  • 2,231 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.